Your trusted source for investing success

Tag: otcqb:rspi

RespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017

RespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI), a leader in the development of medicines for the treatment of respiratory disorders for which there are no approved pharmaceuticals, particularly sleep apneas and respiratory depression resulting from pain management medicines and disabilities such as spinal cord injury, announces that the Company’s President, Chief Executive Officer

RespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017

RespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI), a leader in the development of medicines for the treatment of respiratory disorders, particularly sleep apneas and drug-induced respiratory depression for which there are no approved pharmaceuticals, announces that the Company’s President, Chief Executive Officer and Vice Chairman of the Board of Directors, James S. Manuso,

RespireRx Pharmaceuticals Inc. Announces Positive Results from Phase 2B PACE Study Conducted by the University of Illinois Dronabinol Reduces Symptoms of Obstructive Sleep Apnea

RespireRx Pharmaceuticals Inc. Announces Positive Results from Phase 2B PACE Study Conducted by the University of Illinois Dronabinol Reduces Symptoms of Obstructive Sleep Apnea

RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) is pleased to announce positive results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic Enhancement) trial conducted by Dr. David Carley and colleagues at the University of Illinois at Chicago and Northwestern University. The PACE trial, a Phase 2B study of dronabinol for the treatment

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
RespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/respirerx-pharmaceuticals-inc-present-bio-ceo-investor-conference-2017/